VISIPLEX Trademark
Serial Number: 77320002
VISIPLEX is a trademark filed by
Enzed Nutricorp Inc.
on November 2, 2007. The trademark is classified under Class 5 (Pharmaceuticals).
The application is currently no longer active.
Trademark Classes
Owner Contact Info
Legal Representation
Trademark Details
Filing Date
November 2, 2007
Registration Date
Not Registered
Goods & Services
nutritional supplements to support and treat eye health ailments namely Glaucoma, Macular Degeneration, Night Vision, Cataracts, Stress, Dry Eyes, Eye Strain, and Myopia
Filing History
ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Jun 1, 2010 MAB2
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Jun 1, 2010 ABN2
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Oct 20, 2009 GNS2
INQUIRY TO SUSPENSION E-MAILED
Oct 20, 2009 GNSI
SUSPENSION INQUIRY WRITTEN
Oct 20, 2009 CNSI
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Oct 8, 2009 RCCK
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Apr 6, 2009 GNS3
LETTER OF SUSPENSION E-MAILED
Apr 6, 2009 GNSL
SUSPENSION LETTER WRITTEN
Apr 6, 2009 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Mar 28, 2009 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 28, 2009 CRFA
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Mar 28, 2009 ERSI
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Feb 25, 2009 GNS2
INQUIRY TO SUSPENSION E-MAILED
Feb 25, 2009 GNSI
SUSPENSION INQUIRY WRITTEN
Feb 25, 2009 CNSI
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Feb 18, 2009 RCCK
ASSIGNED TO LIE
Feb 18, 2009 ALIE
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Aug 18, 2008 GNS3
LETTER OF SUSPENSION E-MAILED
Aug 18, 2008 GNSL
SUSPENSION LETTER WRITTEN
Aug 18, 2008 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Aug 15, 2008 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 14, 2008 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Aug 14, 2008 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Feb 15, 2008 GNRN
NON-FINAL ACTION E-MAILED
Feb 15, 2008 GNRT
NON-FINAL ACTION WRITTEN
Feb 15, 2008 CNRT
ASSIGNED TO EXAMINER
Feb 15, 2008 DOCK
NEW APPLICATION ENTERED
Nov 7, 2007 NWAP
